MicroRNAs as new therapeutic targets and tools in cancer

Bibliography

• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
   PubMed Web of Science ®Google Scholar
• Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003;113:673-6
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31
   PubMed Web of Science ®Google Scholar
• Reinhart BJ, Weinstein EG, Rhoades MW, MicroRNAs in plants. Genes Dev 2002;16:1616-26
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835-40
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-9
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;10:2999-3004
   Google Scholar
• Cimmino A, Calin GA, Fabbri M, miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-9
   PubMed Web of Science ®Google Scholar
• Takamizawa J, Konishi H, Yanagisawa K, Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6
   PubMed Web of Science ®Google Scholar
• Johnson SM, Grosshans H, Shingara J, RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47
   PubMed Web of Science ®Google Scholar
• Iorio MV, Casalini P, Piovan C, microRNA-205 regulates HER3 in human breast cancer. Cancer Res 2009;69:2195-200
   PubMed Web of Science ®Google Scholar
• Gregory PA, Bert AG, Paterson EL, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601
   PubMed Web of Science ®Google Scholar
• Gandellini P, Folini M, Longoni N, miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 2009;69:2287-95
   PubMed Web of Science ®Google Scholar
• Ma L, Young J, Prabhala H, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010;12:247-56
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-33
   PubMed Web of Science ®Google Scholar
• Hayashita Y, Osada H, Tatematsu Y, A polycistronic microRNA cluster, miR-17 – 92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32
   PubMed Web of Science ®Google Scholar
• Matsubara H, Takeuchi T, Nishikawa E, Apoptosis induction by antisense oligonucleotides against miR-17 – 5p and miR-20a in lung cancers overexpressing miR-17 – 92. Oncogene 2007;26:6099-105
   PubMed Web of Science ®Google Scholar
• Xiao C, Srinivasan L, Calado DP, Lymphoproliferative disease and autoimmunity in mice with increased miR-17 – 92 expression in lymphocytes. Nat Immunol 2008;9:405-14
   PubMed Web of Science ®Google Scholar
• Olive V, Bennett MJ, Walker JC, miR-19 is a key oncogenic component of mir-17 – 92. Genes Dev 2009;23:2839-49
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005;65:6029-33
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Z, Gao C, miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008;88:1358-66
   PubMed Web of Science ®Google Scholar
• Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005;33:1290-7
   PubMed Web of Science ®Google Scholar
• Corsten MF, Miranda R, Kasmieh R, MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007;67:8994-9000
   PubMed Web of Science ®Google Scholar
• Folini M, Gandellini P, Longoni N, miR-21: an oncomir on strike in prostate cancer. Mol Cancer 2010;9:12
   PubMed Web of Science ®Google Scholar
• Bonci D, Coppola V, Musumeci M, The miR-15a-miR-16 – 1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008;14:1271-7
   PubMed Web of Science ®Google Scholar
• Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010;467:86-90
   PubMed Web of Science ®Google Scholar
• Cho WC. MicroRNAs: potential biomarkers for cancer diagnonis, prognonis and targets therapy. Int J Biochem Cell Biol 2010;42:1273-81
   PubMed Web of Science ®Google Scholar
• Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene 2008;27(Suppl 2):S52-7
   PubMedGoogle Scholar
• Cho WC. MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 2010;1805:209-17
   PubMed Web of Science ®Google Scholar
• Gandellini P, Folini M, Zaffaroni N. Towards the definition of prostate cancer-related microRNAs: where are we now? Trends Mol Med 2009;15:381-90
   PubMed Web of Science ®Google Scholar
• Hutvágner G, Simard MJ, Mello CC, Zamore PD. Sequence-specific inhibition of small RNA function. PLoS Biol 2004;2:e98
   PubMed Web of Science ®Google Scholar
• Meister G, Landthaler M, Dorsett Y, Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004;10:544-50
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005;438:685-9
   PubMed Web of Science ®Google Scholar
• Fontana L, Fiori ME, Albini S, Antagomir-17 – 5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008;3:e2236
   PubMed Web of Science ®Google Scholar
• Felicetti F, Errico MC, Bottero L, The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008;68:2745-54
   PubMed Web of Science ®Google Scholar
• Stenvang J, Silahtaroglu AN, Lindow M, The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol 2008;18:89-102
   PubMed Web of Science ®Google Scholar
• Elmén J, Lindow M, Silahtaroglu A, Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008;36:1153-62
   PubMed Web of Science ®Google Scholar
• Elmén J, Lindow M, Schütz S, LNA-mediated microRNA silencing in non-human primates. Nature 2008;452:896-9
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010;327:198-201
   PubMed Web of Science ®Google Scholar
• Available from: www.ClinicalTrial.gov [Last accessed 9 December 2010]
   Google Scholar
• Delivery on the promise of RNA today, 2010. Available from: www.santaris.com [Last accessed 7 October 2010]
   Google Scholar
• Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010;16:2043-50
   PubMed Web of Science ®Google Scholar
• Gentner B, Schira G, Giustacchini A, Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009;6:63-6
   PubMed Web of Science ®Google Scholar
• Johnnidis JB, Harris MH, Wheeler RT, Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008;451:1125-9
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Young DD, Xiong X, Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008;47:7482-4
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen L, Jung EJ, Calin GA. Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther 2010;87:754-8
   PubMed Web of Science ®Google Scholar
• Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010;70:7027-30
   PubMed Web of Science ®Google Scholar
• Schnepp BC, Clark KR, Klemanski DL, Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol 2003;77:3495-504
   PubMed Web of Science ®Google Scholar
• Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 2006;14:316-27
   PubMed Web of Science ®Google Scholar
• McCarty DM. Self-complementary AAV vectors; advances and applications. Mol Ther 2008;16:1648-56
   PubMed Web of Science ®Google Scholar
• Mueller C, Flotte TR. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 2008;15:858-63
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O'Donnell KA. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-17
   PubMed Web of Science ®Google Scholar
• Takeshita F, Patrawala L, Osaki M, Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010;18:181-7
   PubMed Web of Science ®Google Scholar
• Kovalchuk O, Filkowski J, Meservy J, Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008;7:2152-9
   PubMed Web of Science ®Google Scholar
• Pan YZ, Morris ME, Yu AM. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 2009;75:1374-9
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J, Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 2010;79:817-24
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008;123:372-9
   PubMed Web of Science ®Google Scholar
• Zhu W, Shan X, Wang T, miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010;127:2520-9
   PubMed Web of Science ®Google Scholar
• Mei M, Ren Y, Zhou X, Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat 2010;9:77-86
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhou X, Mei M, MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 2010;10:27
   PubMed Web of Science ®Google Scholar
• Li Z, Hu S, Wang J, MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol 2010;119:125-30
   PubMed Web of Science ®Google Scholar
• Yang H, Kong W, He L, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008;68:425-33
   PubMed Web of Science ®Google Scholar
• Shi L, Chen J, Yang J, MiR-21 protected human glioblastoma U87 MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 2010;1352:255-64
   PubMed Web of Science ®Google Scholar
• Fujita Y, Kojima K, Hamada N, Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008;377:114-9
   PubMed Web of Science ®Google Scholar
• Park JK, Lee EJ, Esau C, Schmittgen TD. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 2009;38:e190-9
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Lang M, Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006;130:2113-29
   PubMed Web of Science ®Google Scholar
• Song B, Wang Y, Titmus MA, Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer 2010;9:96
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Lin J, Yang H, MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008;283:31079-86
   PubMed Web of Science ®Google Scholar
• Shimizu S, Takehara T, Hikita H, The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010;52:698-704
   PubMed Web of Science ®Google Scholar
• Giovannetti E, Funel N, Peters GJ, MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010;70:4528-38
   PubMed Web of Science ®Google Scholar
• Hwang JH, Voortman J, Giovannetti E, Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 2010;5:e10630
   PubMed Web of Science ®Google Scholar
• Eitan R, Kushnir M, Lithwick-Yanai G, Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol 2009;114:253-9
   PubMed Web of Science ®Google Scholar
• Ji J, Shi J, Budhu A, MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009;361:1437-47
   PubMed Web of Science ®Google Scholar
• Ferracin M, Zagatti B, Rizzotto L, MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Mol Cancer 2010;9:123
   PubMed Web of Science ®Google Scholar
• San José-Enériz E, Román-Gómez J, Jiménez-Velasco A, MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Mol Cancer 2009;8:69
   PubMed Web of Science ®Google Scholar
• Moussay E, Palissot V, Vallar L, Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer 2010;9:115
   PubMed Web of Science ®Google Scholar
• Boni V, Zarate R, Villa JC, Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J 2010: published online 29 June 2010; doi: 10.1038/tpj.2010.58
   Google Scholar
• Creighton CJ, Nagaraja AK, Hanash SM, A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 2008;14:2290-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Chaerkady R, Beer MA, Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 2009;9:1374-84
   PubMed Web of Science ®Google Scholar
• Pirollo KF, Zon G, Rait A, Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther 2006;17:117-24
   PubMed Web of Science ®Google Scholar
• McNamara JO 2nd, Andrechek ER, Wang Y, Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 2006;24:1005-15
   PubMed Web of Science ®Google Scholar
• Yu F, Yao H, Zhu P, let-7 Regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007;131:1109-23
   PubMed Web of Science ®Google Scholar